Quick Takeaways
- NOVARTIS PHARMA AG filed SCHEDULE 13G/A for PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share (DTIL).
- Disclosed ownership: 5.4%.
- Date of event: 31 Dec 2024.
NOVARTIS PHARMA AG - 31 Dec 2024 SCHEDULE 13G/A Report for PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share (DTIL)
- Filing Manager
- NOVARTIS PHARMA AG
- Reporting Manager
- Novartis Pharma AG
- Symbol
- DTIL
- Shares outstanding
- 7,658,907 shares
- Disclosed Ownership
- 413,581 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 17:00:56 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 06 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"NOVARTIS PHARMA AG disclosed 5.4% ownership in PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share (DTIL) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 17:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novartis Pharma AG | 5.4% | 413,581 | 0 | 413,581 | /s/ Christian Rehm | Christian Rehm | |
| Novartis AG | 5.4% | 413,581 | 0 | 413,581 | /s/ Christian Rehm | Christian Rehm |